This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Google Scholar Articles by El-Mabhouh, A. A. Articles by Mercer, J. R. PubMed Articles by El-Mabhouh, A. A. Articles by Mercer, J. R.

Unexpected Preferential Brain Metastases with a Human Breast Tumor Cell Line MDA-MB-231 in BALB/c Nude Mice

Faculty of Pharmacy and Pharmaceutical Sciences (AAE-M, JRM), Department of Laboratory Medicine and Pathology (PNN), and Faculty of Medicine and Dentistry (AK, JRM), University of Alberta, Edmonton, Alberta, Canada

Abstract

Animal models are useful tools to study etiology, progress, and new treatments of disease and are an approximation of human disease for experimental study. Intracardiac injection of the human estrogen–independent breast cancer cell line MDA-MB-231 in nude mice is a well-characterized animal model of bone metastasis mainly used to study new treatments for late-stage breast cancer. According to the published literature, this model should produce radiologically distinguishable bone tumors within 17 days after injection. Mice should develop complications such as cachexia, paraplegia, and morbidity within 28 days and require euthanasia within 35 days after injection. We report a study in which injection of MDA-MB-231 cell line led to brain rather than bone metastasis. Unexpected alterations in biological behavior are an important confounding variable in the use of tumor cell lines, and the occurrence and cause of such variants is poorly documented.

Key words: Animal models; experimental mammary neoplasms; mice; neoplasm metastasis.

Request reprints from John R MercerPhD, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 1Z2 (Canada). E-mail: johnmerc{at}cancerboard.ab.ca